INVENTS - Horizon Europe Project

INVENTS "Innovative designs, extrapolation, simulation methods and evidence-tools for rare diseases addressing regulatory needs" is a Europe Horizon project, funded by the European Commission. It started on January 1st, 2024. This projects consists of a consortium of 15 academic and industrial partners. The INVENTS program focuses on advancing the future evaluation of treatments and the regulatory decision-making for Rare Diseases (RD) including paediatric rare diseases. In a 5 years project, INVENTS aims to enhance decision-making by incorporating patient experiences, creating in silico evaluation models from clinical trial or real-world data, and developing regulatory decision support tools for regulatory agencies. Funded by the European Union under grant agreement 101136365. Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them. Funded by the Swiss State Secretariat for Education, Research and Innovation (SERI). Funded by the UKRI Innovate UK under their Horizon Europe Guarantee scheme.